CAS 519055-62-0
:Tasisulam
Description:
Tasisulam is a synthetic compound that belongs to the class of sulfonamide derivatives, primarily investigated for its potential therapeutic applications, particularly in oncology. It functions as an inhibitor of certain cellular pathways, which may contribute to its anticancer properties. Tasisulam has been studied for its ability to induce apoptosis in cancer cells and inhibit tumor growth. The compound is characterized by its unique chemical structure, which includes a sulfonamide group, contributing to its biological activity. It is typically administered in a clinical setting, and its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are crucial for understanding its efficacy and safety profile. As with many investigational drugs, ongoing research aims to elucidate its mechanism of action, optimal dosing regimens, and potential side effects. Overall, tasisulam represents a promising candidate in the field of cancer therapeutics, although further studies are necessary to fully establish its clinical utility and effectiveness.
Formula:C11H6BrCl2NO3S2
Synonyms:- N-(2,4-Dichlorobenzoyl)-5-bromothiophene-2-sulfonamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Tasisulam
CAS:Formula:C11H6BrCl2NO3S2Purity:>95.0%(HPLC)(qNMR)Color and Shape:White to Light yellow powder to crystalMolecular weight:415.10Tasisulam
CAS:Tasisulam (LY573636) is an apoptosis inducer and an antitumor agent via the intrinsic pathway.Formula:C11H6BrCl2NO3S2Purity:99% - >99.99%Color and Shape:SolidMolecular weight:415.11
